Brain metastasis PD-L1 and CD8 expression is dependent on primary tumor type and its PD-L1 and CD8 status

BACKGROUND: Brain metastases (Bmets) are frequent; however, limited data exist on the efficacy of immunotherapy in these lesions. The aims of the study were to analyze the immunohistochemical expressions of programmed death ligand 1 (PD-L1) and CD8 in Bmets and to compare them with their expressions...

Descripción completa

Detalles Bibliográficos
Autores principales: Camy, Florian, Karpathiou, Georgia, Dumollard, Jean Marc, Magne, Nicolas, Perrot, Jean Luc, Vassal, Francois, Picot, Tiphanie, Mobarki, Mousa, Forest, Fabien, Casteillo, Francois, Hathroubi, Sirine, Froudarakis, Marios, Peoc'h, Michel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Immunotherapy Biomarkers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7454240/
https://www.ncbi.nlm.nih.gov/pubmed/32859740
http://dx.doi.org/10.1136/jitc-2020-000597

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7454240/
https://www.ncbi.nlm.nih.gov/pubmed/32859740
http://dx.doi.org/10.1136/jitc-2020-000597

Ejemplares similares